biomarker panel | GenomeWeb

biomarker panel

Angsana will support a Phase 2 basket trial for a tyrosine kinase inhibitor that targets tumors harboring TRK, ROS1, and ALK fusions.

The company is preparing a blood-based test for early-stage pancreatic cancer that it hopes to have on the market by 2019.

The company's new blood-based test is the first clinical test offering that the company will be offering at its New York-based CLIA laboratory.

N-of-One will identify the most relevant therapeutic options for each patient tested with Admera's 64-gene oncology panel.

Full-year revenues fell 22 percent, which the company said was due to a decrease in the number of kits being returned for processing. 

The company's recent experience demonstrates the impasse between genetic test developers and payors about the types of clinical evidence needed for coverage.

The companies are co-developing an assay that differentiates previously infected, seropositive Lyme disease patients from newly infected individuals.

OmniSeq's goal is to make cancer genomic testing available to institutions, including comprehensive cancer centers, oncology practices, and community oncology groups.

NEW YORK (GenomeWeb) – Cancer Genetics today said that it will collaborate with a researcher at Keck Medicine of the University of Southern California to identify genomic markers of diffuse large B-cell lymphoma.

NEW YORK (GenomeWeb) — Data presented earlier this month at the 2014 European League Against Rheumatism (EULAR) Annual Congress by Crescendo Bioscience has added upon earlier retrospective data supporting the clinical utility of the company's Vectra DA test in measuring disease activity and predi

Pages

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.